Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac)
✍ Scribed by Takeshi Yoshida; Junsong Gong; Zhenhua Xu; Yanhong Wei; Elia J. Duh
- Book ID
- 116457278
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 963 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0014-4835
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
This study was performed to determine whether a highly selective nonpeptide ␣ v  3 antagonist (SH306) would prove effective in inhibiting neointima formation in a rabbit cuff model. The animals were dosed with SH306, 5 mg/kg i.v., followed by 10 mg/kg s.c., 3 times daily for 3 days, or with vehicle
## Abstract The interaction between the arginine glycine and aspartic acid motif (RGD) of integrin ligands such as vitronectin and the integrin receptor αVβ3 in mediating cell attachment has been well described. Similarly, the ability of disintegrins, small RGD containing peptides, to inhibit cell
Vascular smooth muscle cell growth-promoting factor (VSGP) was originally isolated from bovine ovarian follicular fluid as a stimulator of vascular smooth muscle cell proliferation. Homology searches indicate that bovine and human VSGPs are orthologs of rat F-spondin. Here, we examined whether recom